Conducted: Ames, chromosomal aberration in mammalian cells, mouse micronucleus; all negative
“Avacincaptad pegol was negative for genotoxicity based on a standard battery of studies including the bacterial reverse mutation assay, chromosomal aberration in mammalian cells and in vivo mouse bone marrow micronucleus assays.”
✓ VerifiedFDA pharmacology/toxicology review, p. 8Source ↗
Carcinogenicity
Not conducted (waiver accepted; low systemic exposure, C5-inhibitor class experience)
“Carcinogenicity No studies were conducted. The Applicant submitted a justification to support a waiver request not to conduct the carcinogenicity studies”
✓ VerifiedFDA pharmacology/toxicology review, p. 69Source ↗
Reproductive & developmental
EFD studies in rat and rabbit (IV, NOAEL 1.2 mg/kg/day); FEED and PPND waived
“In the embryofetal development (EFD) toxicity studies in rats and rabbits, there was no avacincaptad pegol-related adverse effects on any measured maternal or fetal parameter at doses up to 1.2 mg/kg/day (NOAEL).”
✓ VerifiedFDA pharmacology/toxicology review, p. 8Source ↗